Practical experience in implementing surveillance of antiviral resistance in several European countries in accordance with personal data regulation
|
|
|
- Derek Osborne
- 5 years ago
- Views:
Transcription
1 Practical experience in implementing surveillance of antiviral resistance in several European countries in accordance with personal data regulation Katja Deterding Medizinische Hochschule Hannover
2 Antiviral drug resistance: Viral Hepatitis Hepatitis B (PEG-) Interferon alpha Nucleos(t)ides Combination therapies Hepatitis C PEG-Interferon alpha + Ribavirin New antivirals ( Enzyme inhibitors, etc. )
3 VIRGIL European Network of Excellence integrating the expertise of national networks + ISRAEL
4 VIRGIL Network Composition 12 European member states 55 Institutions Steering committee 60 Project Management Scientific Teams Governing Board Scientific Advisory Board Patients Advocacy Groups 7 Companies Bioalliance BioMérieux LiverDoc Retroscreen Riotech Tripep
5 VIRGIL - Platforms
6 VIRGIL Surveillance Platform PARTNERS IN HEPATITIS SURVEILLANCE Medizinische Hochschule Hannover Medizinische Hochschule Hannover (Germany) (Germany) Michael Manns Michael Manns Ludwig Maximilians Universität Ludwig Maximilians Universität München (Germany) München (Germany) T Mueller T Mueller AIES-Hospital Carlos III AIES-Hospital Carlos III (Italy) (Italy) V Soriano V Soriano Hospital Clínic Provincial de Hospital Clínic Provincial de Barcelona (Spain) Barcelona (Spain) X Forns X Forns Inserm (France) Inserm (France) C Trepo / F Zoulim C Trepo / F Zoulim C Brechot C Brechot The University of Birmingham The University of Birmingham (UK) (UK) D Mutimer D Mutimer University of Gdansk Faculty University of Gdansk Faculty of Biotechnology (Poland) A of Biotechnology (Poland) A Podhajska Podhajska Papageorgious General Papageorgious General Hospital (Greece) Hospital (Greece) G Germanidis G Germanidis Azienda Ospedaliera di Parma Azienda Ospedaliera di Parma (Italy) (Italy) C Ferrari C Ferrari Hospital Universitario Valle Hospital Universitario Valle Hebron (Spain) Hebron (Spain) R Esteban Mur / M Buti R Esteban Mur / M Buti Karolinska Institutet Karolinska Institutet (Sweden) (Sweden) O Weiland / M Sällberg O Weiland / M Sällberg Université Catholique de Université Catholique de Louvain (Belgium) Louvain (Belgium) E Sokal E Sokal Université Paris XII-Val-de- Université Paris XII-Val-de- Marne (France) Marne (France) JM Pawlotsky JM Pawlotsky Tripep AB Tripep AB (Sweden) (Sweden) A Vahlne A Vahlne Charité Campus Virchow-Klinikum Charité Campus Virchow-Klinikum Uni Berlin (Ger) Uni Berlin (Ger) T Berg T Berg Imperial College of Science (UK) Imperial College of Science (UK) H Thomas H Thomas University of Bari University of Bari (Italy) (Italy) G Pastore / T Santantonio G Pastore / T Santantonio Université de Genève Université de Genève (Swizterland) (Swizterland) F Negro F Negro Universität des Saarlandes Universität des Saarlandes (Germany) (Germany) S Zeuzem S Zeuzem Venetian Institute of Molecular Venetian Institute of Molecular Medicine (Italy) A Alberti Medicine (Italy) A Alberti
7 Integration of local existing networks EISS Virgil-Flu Virgil-Hepatitis UK MRC cooperative Infectious Disease network Sweden Local cohorts Stockholm Hep-Net Germany Italy Local network north East Italy France ANRS Local cohorts Lyon, Paris Spain Local cohorts Madrid, Barcelona Switzerland Swiss Hepatitis Network Netherlands Local cohorts
8 Main Aims of the SURVEILLANCE Network Minimise emergence and spread of antiviral drug resistance in cooperation with the other platforms Quality control European IT- platform Research of special patient groups SURVEIL Central serum bank Information on the prevalence and spread of viral resistant strains in Europe European online database for the documentation of patients with antiviral drug resistance
9 VIRGIL - Online Database
10 European database 1. Central Database for Europe and comprehensive IT- platform 2. Serum samples Basis for other projects,, e.g. investigation of viral and host mechanisms of drug resistance
11 VIRGIL - Online Database Data about treatment failures Information flow backwards about resistance testing WEB-DATABASE Clinvir-Platform [complete testing only in cases with highly probable resistance] Surveil centers in EU Models Host Innotech
12 Case report forms online documentation 1. Standard documentation 2. Primary documentation 3. Documentation of the clinical course 4. End of documentation
13 Cooperation Surveil /Clinvir - interim solution - Local Sites Report CRFs Surveil Central Sequence Data Serum Samples Clinvir Central
14 Patient informed consent form - available in 9 different languages English German French Italian Spanish Dutch Swedish Greek Polish Türkish Russian
15
16 VIRGIL - Online Database Positive Votum from the ethics committee Hannover
17 VIRGIL - Online Database The following documents were sent to all Virgil Surveillance partners and all additional clinicans within the Virgil Network Study protocoll Patient informed consent forms Positive votum from the ethics committee Hannover Case report forms all partners were ask to get in contact with their own ethics committee
18 Problems in different countries: Insurance Different patient groups e.g. children
19 Virgil online database: Two ways of documentation 1. Patients who have signed the informed consent form before or at the date of data entry should be entered as pseudonymised/ identifiable patients (documentation with patient initials) 2. Patients who have not signed the informed consent form before or at the date of data entry should be entered as anonymised patients. (documentation without patient initials)
20 VIRGIL - Online Database Every Hepatitis B (D) and Hepatitis C patient with ongoing or previous antiviral treatment should be entered in the Virgil online database Every Virgil partner will receive a user name and a password to link via internet to the database It must be documented at each center wich patient belongs to which patient number!!!
21 VIRGIL - Online Database 1. Standard Documentation
22 2. Primary Documentation
23 3. Follow-up
24 Serum samples Every serum sample should be registered in the database before shipment Enter the clinical data Click on: SERUM SAMPLES WILL BE SEND You will receive a sample-id, wich should be written on the tube before shipment The link between patient-id (clinical data) and serum-id (analysis) is only possible for the IT-Platform (Thomas Müller)
25 Summary Different legal issues in the european countries, especially for the shipment of serum samples Different patient groups, e.g. children Different regulations concering the patient insurance Differentiation between anonymised and pseudonymised documentation In some european countries is one central ethics votum not sufficient
26
PHOTO. VHPB/ELPA MEETING Prevention and Control of Viral Hepatitis The role and impact of patients and advocacy groups in and outside Europe
www.eurordis.org VHPB/ELPA MEETING Prevention and Control of Viral Hepatitis The role and impact of patients and advocacy groups in and outside Europe Lucca ( Italy ) March 13-14, 2008 PHOTO www.eurordis.org
European Patients Academy on Therapeutic Innovation
European Patients Academy on Therapeutic Innovation http://www.patientsacademy.eu info@patientsacademy.eu The project is receiving support from the Innovative Medicines Initiative Joint Undertaking under
Angelos Hatzakis. 10th Paris Hepatology Conference
Angelos Hatzakis Professor of Epidemiology and Preventive Medicine Faculty of Medicine National and Kapodistrian University of Athens Co-Chair, Hepatitis B and C Public Policy Association 10th Paris Hepatology
The Academy for Clinical Debates & Controversies in Medicine C-HEP CONTROVERSIES IN THE MANAGEMENT OF VIRAL HEPATITIS BARCELONA SPAIN MAY 19-22, 2011
The Academy for Clinical Debates & Controversies in Medicine C-HEP 1 st World Congress on CONTROVERSIES IN THE MANAGEMENT OF VIRAL HEPATITIS Second ANNOUNCEMENT Last update: February 1, 2011 www.comtecmed.com/chep
The Academy for Clinical Debates & Controversies in Medicine C-HEP BARCELONA SPAIN MAY 19-22, 2011 ANNOUNCEMENT
The Academy for Clinical Debates & Controversies in Medicine C-HEP 1 st World Congress on CONTROVERSIES IN THE MANAGEMENT OF VIRAL HEPATITIS Second ANNOUNCEMENT Last update: March 9, 2011 www.comtecmed.com/chep
MEETING PROSPECTUS www.virology-education.com CONTENT Introduction... 3 Workshop description... 4 Background...4 Meeting Objectives...4 Learning Objectives...4 Format...4 Unique Meeting Features...4 Target
Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA)
Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) Guidelines for Users May 2016 B1 Chorlton Mill, 3 Cambridge Street, Manchester, M1 5BY, UK Tel: +44 (0)161 226 4446 Fax: +44
COMMITTEE OF EXPERTS ON THE CLASSIFICATION OF MEDICINES AS REGARDS THEIR SUPPLY (CD-P-PH/PHO) PROGRAMME RESULTS
COMMITTEE OF EXPERTS ON THE CLASSIFICATION OF MEDICINES AS REGARDS THEIR SUPPLY (CD-P-PH/PHO) PROGRAMME RESULTS 2016-2017 Introduction This summary provides an overview of the activities carried out by
Hearing Loss: The Statistics
: The Statistics 2015 Global Statistics It is hard to know precise numbers of how many people experience hearing loss across the EU, Europe, and indeed the world. There are many sources of information
Table Of Content. Outputs... 9
Table Of Content European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment... 2 Summary... 3 Coordinator, Leader contact and partners... 5 Klinikum Dortmund ggmbh... 5 Uniwersytet
Need for Chronic Viral Hepatitis Monitoring System
Need for Chronic Viral Hepatitis Monitoring System Harry L.A. Janssen Dept. of Gastroenterology & Hepatology Erasmus University Medical Center Rotterdam The Netherlands Rotterdam November 2008 National
Table Of Content. The European Influenza Surveillance Scheme... 2 Summary... 3 Coordinator, Leader contact and partners Outputs...
Table Of Content The European Influenza Surveillance Scheme... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Institut Pasteur... 6 Health Division... 6 Nphs Communicable Disease Surveillance
Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA
Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA January 2016 Summary This report describes the geographical and temporal distribution of multidrug-resistant (MDR) tuberculosis
LYON. FRANCE NOVEMBER / 2013 TRANSLATIONAL RESEARCH IN CHRONIC VIRAL HEPATITIS - BRIDGING BASIC SCIENCE AND CLINICAL RESEARCH
LYON. FRANCE NOVEMBER 29-30 / 2013 TRANSLATIONAL RESEARCH IN CHRONIC VIRAL HEPATITIS - BRIDGING BASIC SCIENCE https://events.easl.eu/eventportal/ Information/MLYON2013/HOME.aspx Abstract submission deadline:
Building Towers in Babel: ACT-RFT in English speaking countries. manuals and self-help books. speaking countries? ACBS web site
Building Towers in Babel: Spreading and sharing knowledge, translating manuals and self-help books M. Villatte,, JL Monestès,, & G. Presti /7 ACT-RFT in English speaking countries ACBS web site ACT Therapists
ASC-Inclusion. The Case, Initiatives and Impact. Interactive Emotion Games. Björn Schuller
ASC-Inclusion Interactive Emotion Games The Case, Initiatives and Impact Björn Schuller Institute for Human-Machine Interaction Technische Universität München, Germany DGEI Expert Workshop, 23/24 January
Behavioural indicators in men who have sex with men
Behavioural indicators in men who have sex with men Dr. Brenda Spencer, IUMSP, Lausanne 13 th HIV/AIDS Think Tank Meeting First presented by Prof. Jonathan Elford, City University London European Parliament,
NATIONAL REGISTRIES OF RARE DISEASES IN EUROPE: AN OVERVIEW BY THE EPIRARE PROJECT.
D. Taruscio and L. Vittozzi National Centre for Rare Diseases National Institute of Health Rome, Italy NATIONAL REGISTRIES OF RARE DISEASES IN EUROPE: AN OVERVIEW BY THE EPIRARE PROJECT. ICORD 2014, Ede
Results of histopathological thrombus evaluation in patients presenting with stent thrombosis across Europe: a report of the PRESTIGE Consortium
Results of histopathological thrombus evaluation in patients presenting with stent thrombosis across Europe: a report of the PRESTIGE Consortium Dr. med. Julia Riegger Medizinische Klinik u. Poliklinik
Table Of Content. Invasive Bacterial Infections Surveillance in the European Union... 2 Summary... 3 Coordinator, Leader contact and partners...
Table Of Content Invasive Bacterial Infections Surveillance in the European Union... 2 Summary... 3 Coordinator, Leader contact and partners... 5 National School of Public Health... 5 National Institute
Cups & Filters. 2.5ml sterile cup 100 pcs bag 100 and more Handle. Cotton filter 1000 pcs carton 5000 and more
Tools for harm reduction Tél: +33 (0) 1 53 61 18 41 - Fax: +33 (0) 1 53 61 04 49 Cups & Filters Tool Composition Packaging Quantity Number of pieces Total Stericup* 2.5ml sterile cup 100 pcs bag 100 and
10 5 TH TH WORKSHOP INTERNATIONAL WORKSHOP ON CO-INFECTION NEW ANTIVIRALS IN CLINICAL PRACTICE HIV & HEPATITIS AMSTERDAM, PARIS, FRANCE THE NETHERLANDS 12-13 JUNE 2014 4-5 DECEMBER 2015 MEETING PROSPECTUS
Table Of Content. Outputs... 9
Table Of Content Development & Implementation of a European Guideline and training standards for Diabetes Prevention... 2 Summary... 3 Coordinator, Leader contact and partners... 4 University of Oslo...
Emerging Risks Mapping of Activities in Member States. 67th Advisory Forum meeting, Utrecht, The Netherlands, 6 February 2018
Emerging Risks Mapping of Activities in Member States 67th Advisory Forum meeting, Utrecht, The Netherlands, 6 February 2018 BACKGROUND 67 th Advisory Forum Meeting, Utrecht, The Netherlands, 6 February
Influence of Baseline HCV Genotype upon Treatment Outcome of Acute HCV Infection in HIV Co-Infected Individuals
Influence of Baseline HCV Genotype upon Treatment Outcome of Acute HCV Infection in HIV Co-Infected Individuals Christoph Boesecke, Hans-Jürgen Stellbrink, Stefan Mauss, Emma Page, Mark Nelson, Sanjay
WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017
WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017 Mary L. Yost 404-520-6652 , LLC 23 Ridge Rd. Beaufort, SC 20097 Copyright Pending 2017 All rights reserved,
The European network for paediatric research. Carlo Giaquinto University of Padova Padova
The European network for paediatric research Carlo Giaquinto University of Padova Padova Types of Paediatric networks (examples) Clinical Trials networks: National networks (MCRN, FinPedMed, CICPed, PaedNet
rare diseases research through National Plans and Strategies
Recommendations to support rare diseases research through National Plans and Strategies Dr Domenica Taruscio EUROPLAN Coordinator Director of the Italian Centre for Rare Diseases, Italian National Institute
A Global Patient Registry for Human Avian Influenza
A Global Patient Registry for Human Avian Influenza Understanding Clinical Presentation, Treatment Outcomes, and Survival Introduction September, 2008 Human Avian Influenza represents a major concern for
GOOD MORNING AND WELCOME. The International Liver Congress Berlin, April 2011
GOOD MORNING AND WELCOME The International Liver Congress Berlin, April 2011 INTRODUCTION AND AIMS PROTOCOL OVERVIEW, CRF AND OTHER FORMS PROTOCOL OVERVIEW: INCLUSION CRITERIA HBsAg + antihdv + 18 years
The European Reference Network in Rare Hematological Diseases
The European Reference Network in Rare Hematological Diseases Pierre Fenaux ERN-EuroBloodNet coordinator www.eurobloodnet.eu The context of ERNs Share. Care. Cure. Due to the small patient number and the
EUROPEAN SURVEY OF CARDIOVASCULAR DISEASE PREVENTION AND DIABETES EUROASPIRE IV. GUY DE BACKER Ghent University,Belgium
EUROPEAN SURVEY OF CARDIOVASCULAR DISEASE PREVENTION AND DIABETES EUROASPIRE IV GUY DE BACKER Ghent University,Belgium ESC Congress 2012, aug.25-29th, Munich, Germany ESC Congress 2012, aug.25-29th, Munich,
European Status report on Alcohol and Health
European Status report on Alcohol and Health Dr Lars Moller Regional Advisor a.i. WHO Regional Office for Europe Main killers in the WHO European Region Source: Preventing chronic diseases. A vital investment.
EUVAC.NET A surveillance network for vaccine-preventable diseases
EUVAC.NET A surveillance network for vaccine-preventable diseases Mark Muscat EUVAC.NET Co-ordinator Department of Epidemiology Statens Serum Institut Denmark Email: mmc@ssi.dk Viral Hepatitis Prevention
The Identification of Food Safety Priorities using the Delphi Technique
The Identification of Food Safety Priorities using the Delphi Technique Gene Rowe & Fergus Bolger, GRE 58th Advisory Forum Meeting, Luxembourg, 8-9 December 2015 EU RISK ASSESSMENT AGENDA (RAA) where priorities
Dr Claire Townsend on behalf of EPPICC. Presented at the 2 nd International Workshop on HIV Pediatrics July 2010, Vienna Austria
Response to early antiretroviral treatment in HIV-infected infants: the experience of the European Pregnancy & Paediatric HIV Cohort Collaboration (EPPICC) Dr Claire Townsend on behalf of EPPICC Background
Integrating the Healthcare Enterprise The IHE Initiative Worldwide IHE Europe Karima Bourquard IHE Europe user Cochair
Integrating the Healthcare Enterprise IHE Europe Karima Bourquard IHE Europe user Cochair February 29, 2008 1 Agenda Introduction Projects in Europe : IHE-Europe Status National IHE initiatives : Who are
Assessment of sofosbuvir (Sovaldi )
Assessment of sofosbuvir (Sovaldi ) Summary of the national assessments of sofosbuvir (Sovaldi ) for the treatment of Hepatitis C December 18, 2014 Health Care Institute, Diemen, NL Lead Partner WP5 EUnetHTA
Media monitoring: Experience of outbreak monitoring at ECDC to monitor vaccine safety potential crisis- A pilot using MediSYS
Media monitoring: Experience of outbreak monitoring at ECDC to monitor vaccine safety potential crisis- A pilot using MediSYS Building Trust, Managing Risk: Vaccine Confidence and Human Papillomavirus
OVARIAN. CANCER Optimal Therapy. Update ADVANCED. 12 th International Symposium. Valencia, 22 nd February
Organized by Valencia, 22 nd February 2019 12 th International Symposium ADVANCED OVARIAN CANCER Optimal Therapy. Update DIRECTORS Andrés Poveda Initia Oncology, Hospital Quirónsalud, Valencia, Spain Jan
11 TH INTERNATIONAL WORKSHOP ON CO-INFECTION HIV & HEPATITIS LONDON, UNITED KINGDOM 11-12 JUNE 2015 MEETING PROSPECTUS www.virology-education.com CONTENT Introduction... 3 Workshop description... 4 Background...
Developing the Framework for an Epidemic Forecast Infrastructure
Information and Communication Technologies Developing the Framework for an Epidemic Forecast Infrastructure http://www.epiwork.eu Project no. 231807 D5.8 Gradual implementation of IMS and its Internet
Towards Integrated Syndromic Surveillance in Europe?
Towards Integrated Syndromic Surveillance in Europe? Duncan Cooper - Born in Bradford Research Study, UK Triple-S partners including Anette Hulth, Alexandra Ziemann, Jean-Babtiste Perrin, Mark Kanieff,
Summary. Primary care data. Week 49/2014. Season
Summary Week 49/2014 In week 49/2014, influenza activity remained low across the WHO European Region. Twenty countries reported sporadic influenza activity and nine reported increasing trends in consultations
Hep-CORE, Marinela Debu, ELPA vice-president & APAH-RO president
Hep-CORE, 2017 Marinela Debu, ELPA vice-president & APAH-RO president Hep-CORE Monitoring the implementation of hepatitis B and C policy recommendations in Europe The only European viral hepatitis policy
The HCV pipeline: Will IFN-free treatment be possible? Heiner Wedemeyer. Hannover Medical School Germany
: Will IFN-free treatment be possible? Heiner Wedemeyer Hannover Medical School Germany Interferon-free regimens to treat hepatitis C What should be the goal of interferon-free treatment regimens: Sustained
Joint Programming in Neurodegenerative Disease Research (JPND)
Joint Programming in Neurodegenerative Disease Research (JPND) Building Alliances and Collaborations Prof. Philippe Amouyel, MD, PhD JPND Chair France Disclosure CEO of Fondation Plan Alzheimer Conference
Smokefree Policies in Europe: Are we there yet?
Smokefree Policies in Europe: Are we there yet? 14 April 2015, 9:00 10:30am Rue de l Industrie 24, 1040 Brussels Permanent Partners: Temporary Partners: The research for the SFP Smokefree Map was partially
ECDC and Spanish Ministry of Health workshop:
ECDC and Spanish Ministry of Health workshop: Improving the monitoring of HIV among migrant populations in Europe, Madrid, 3-4 October 2013 Teymur Noori EU Commission Thank Tank on HIV/AIDS Luxembourg,
Screening for hepatitis B and C among migrants in the European Union
Screening for hepatitis B and C among migrants in the European Union Conference on Migrants and Health 12 th May 2016, Lisbon, Portugal Amena Ahmad Hamburg University of Applied Sciences Germany Email:
WCPT COUNTRY PROFILE December 2017 SWEDEN
WCPT COUNTRY PROFILE December 2017 SWEDEN SWEDEN NUMBERS WCPT Members Practising physical therapists 11,043 Total number of physical therapist members in your member organisation 17,906 Total number of
Duration of first line antiretroviral therapy (ART) in children in the European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC)
Duration of first line antiretroviral therapy (ART) in children in the European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) Ruth Goodall, Intira Jeannie Collins (MRC CTU at UCL), Luminita
Weekly influenza surveillance overview
SURVEILLANCE REPORT Weekly influenza surveillance overview 7 February 2014 Main surveillance developments in week 5/2014 (27 January 2014 2 February 2014) This first page contains the main developments
Liver disease in 2017: challenges and opportunities
Liver disease in 2017: challenges and opportunities Dr Matthew Cowan Consultant Gastroenterologist and Hepatologist Surrey and Sussex Healthcare NHS Trust Faculty of Physician Associates 2 nd National
Interferon alfa therapy is now widely recommended for
GASTROENTEROLOGY 1999;117:408 413 Interferon-Ribavirin for Chronic Hepatitis C With and Without Cirrhosis: Analysis of Individual Patient Data of Six Controlled Trials SOLKO W. SCHALM,* OLA WEILAND, BETTINA
WCPT COUNTRY PROFILE December 2017 HUNGARY
WCPT COUNTRY PROFILE December 2017 HUNGARY HUNGARY NUMBERS WCPT Members Practising physical therapists 727 Total number of physical therapist members in your member organisation 4,000 Total number of practising
LEBANON. WCPT COUNTRY PROFILE December 2018
LEBANON WCPT COUNTRY PROFILE December 2018 LEBANON NUMBERS 1600 1400 1200 1000 800 600 400 200 0 Physical therapists in the country Members in MO 1,480 1,480 Total PTs in country 800000 700000 600000 500000
WCPT COUNTRY PROFILE December 2017 SERBIA
WCPT COUNTRY PROFILE December 2017 SERBIA SERBIA NUMBERS WCPT Members Practising physical therapists 622 Total number of physical therapist members in your member organisation 3,323 Total number of practising
Table Of Content. European Surveillance of Congenital Anomalies (Phase 3)... 3 Summary... 4 Coordinator, Leader contact and partners...
Table Of Content European Surveillance of Congenital Anomalies (Phase 3)... 3 Summary... 4 Coordinator, Leader contact and partners... 5 Registry of Congenital Anomalies... 5 CNR Institute of Clinical
European Dietetic Action Plan Progress report 2017
European Dietetic Action Plan Progress report 2017 Samantha Cushen, EFAD Project Manager Annemieke van Ginkel-Res,Honorary President 29 September 2018 EFAD The European Dietitians www.efad.org 1 EuDAP
Table Of Content. Outputs... 7
Table Of Content Using Multidimensional Prognostic Indices(MPI)to improve costeffectiveness of interventions in multimorbid frail older persons.... 2 Summary... 3 Coordinator, Leader contact and partners...
15 & 16 January International Conference on the Management of Liver Diseases. Organised by Pr Patrick Marcellin
15 & 16 January 2018 PARIS - Palais des Congrès International Conference on the Management of Liver Diseases Organised by Pr Patrick Marcellin Organising Committee Blaise Kutala, Monelle Muntlak Hôpital
Perspectives for information on alcohol use in the EU
EMCDDA Perspectives for information on alcohol use in the EU Julian Vicente Luxembourg 20-21 March 2018 CNAPA meeting Topics in this presentation ESPAD project (now with EMCDDA) in students Alcohol ( Tobacco
Key issues for HIV testing and
Key issues for HIV testing and counselling in Europe Martin C Donoghoe Programme Manager HIV/AIDS, STI &Viral Hepatitis Programme WHO Europe Key issues for HIV testing & counselling in Europe HIV epidemics
Prevention and control of viral hepatitis: Role and impact of liver patient groups in Europe. The Netherlands National hepatitis Centre
Prevention and control of viral hepatitis: Role and impact of liver patient groups in Europe. The Netherlands National hepatitis Centre 1) History of the organisation(s) Founded in 1997 by: Dutch liver
DENMARK. WCPT COUNTRY PROFILE December 2018
DENMARK WCPT COUNTRY PROFILE December 2018 DENMARK NUMBERS 14000 12000 10000 8000 6000 4000 2000 0 Physical therapists in the country Members in MO 11,720 12,975 Total PTs in country 800000 700000 600000
activism Animal Ethics in 2017 A year in retrospect:
A year in retrospect: Animal Ethics activism in 2017 In 2017, Animal Ethics expanded its work further, reaching new places and people, and we anticipate great advances during the next year. Here is a summary
EPAG UPDATE. Lenja Wiehe. European Patient Advocacy Groups Manager, EURORDIS
EPAG UPDATE Lenja Wiehe European Patient Advocacy Groups Manager, EURORDIS Patient Centre & Empowerment European Reference Networks (ERNs) created on founding principles of patient-centred care, patient
ECOO European Diploma in Optometry and Optics ECOO European Diploma in Optics A Status Report
ECOO European Diploma in Optometry and Optics ECOO European Diploma in Optics A Status Report Peter Gumpelmayer, BOptom, EurOptom ECOO President-elect ECOO The European Council of Optometry and Optics
Genetic and environmental risk factors for melanoma: translation into behavioural change
Genetic and environmental risk factors for melanoma: translation into behavioural change A Network of Excellence Project Funded by the EC Sixth Framework Programme PRIORITY 1 Life sciences, genomics and
INCIDENCE OF ADENOVIRUS INFECTIONS IN PEDIATRIC AND ADULT ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS IN EUROPE
INCIDENCE OF ADENOVIRUS INFECTIONS IN PEDIATRIC AND ADULT ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS IN EUROPE Sebastian Voigt, 1 Cécile Pochon, 2 Kanchan Rao, 3 Antonio Pérez-Martínez, 4 Marco
GERMANY. WCPT COUNTRY PROFILE December 2018
GERMANY WCPT COUNTRY PROFILE December 2018 GERMANY NUMBERS 160000 140000 120000 100000 80000 60000 40000 20000 0 Physical therapists in the country Members in MO 21,502 136,000 Total PTs in country 800000
Overview of drug-induced deaths in Europe - What does the data tell us?
Overview of drug-induced deaths in Europe - What does the data tell us? João Matias, Isabelle Giraudon, Julián Vicente EMCDDA expert group on the key-indicator Drug-related deaths and mortality among drug
CALL FOR A EUROPEAN ACTION PLAN FOR MEDICAL IMAGING TO IMPROVE QUALITY OF CARE AND PATIENT SAFETY
CALL FOR A EUROPEAN ACTION PLAN FOR MEDICAL IMAGING TO IMPROVE QUALITY OF CARE AND PATIENT SAFETY myesr.org QUALITY & SAFETY Improving and harmonising quality and safety in medical imaging across Europe
The current status of PrEP in Europe. Pep Coll AIDS Research Institute-IrsiCaixa Fight AIDS Foundation BCN Checkpoint
The current status of PrEP in Europe Pep Coll AIDS Research Institute-IrsiCaixa Fight AIDS Foundation BCN Checkpoint DISCLOSURES I have received a research grant from Gilead Sciences awarded to my institution
Clinical Сase A previously relapse to PEG IFN + RBV in HCV G3a patient. Konstantin Zhdanov
Clinical Сase A previously relapse to PEG IFN + RBV in HCV G3a patient Konstantin Zhdanov Genotype 3 in Europe Canada Norway Germany Sweden Czech Republic Poland Approximately 1/3 of HCV-infected patients
World Connections Committee (WCC) Report
World Connections Committee (WCC) Report 06 Co-Dependents Anonymous Service Conference Countries Where CoDA Exists This report reflects the World Connections Committee (WCC) support of the growth and development
Network Meeting for Prison and Health. Kyiv, Ukraine 14 November December Summary report
HEALTH ORGANIZATION REGIONAL OFFICE FOR EUROPE WELTGESUNDHEITSORGANISAT ION REGIONALBÜRO FÜR EUROPA ORGANISATION MONDIALE DE LA SANTÉ BUREAU RÉGIONAL DE L'EUROPE ВСЕМИРНАЯ ОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯ ЕВРОПЕЙСКОЕ
Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA
SURVEILLANCE REPORT Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA March 2017 Summary This report describes the geographical and temporal distribution of multidrug-resistant
HPV, Cancer and the Vaccination Programme
HPV, Cancer and the Vaccination Programme Dr Brenda Corcoran Consultant in Public Health Medicine HSE National Immunisation Office What is HPV? Human papillomavirus Over 200 types identified Spread by
Table Of Content. European Collaboration on Dementia... 2 Summary... 3 Coordinator, Leader contact and partners Outputs...
Table Of Content European Collaboration on Dementia... 2 Summary... 3 Coordinator, Leader contact and partners... 5 Associacao Portuguesa de Familiares e Amigos de Doentes de Alzheimer... 5 Universiteit
Hepatitis A SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods
SURVEILLANCE REPORT Annual Epidemiological Report for 2015 Hepatitis A Key facts In 2015, 29 EU/EEA countries reported a total of 12 641 cases of hepatitis A, 12 527 (99.1%) of which were confirmed. The
Overview of European Consumption Databases
FEDERAL INSTITUTE FOR RISK ASSESSMENT Overview of European Consumption Databases Katrin Büsch Workshop Food Consumption Data and Dietary Exposure in the European Union, 15-16 May 2008, Berlin Introduction
Building the European Reference Network for Rare Endocrine Conditions (Endo-ERN) Journee Annuelle, FIRENDO, Paris, 14 december 2016
Building the European Reference Network for Rare Endocrine Conditions (Endo-ERN) Journee Annuelle, FIRENDO, Paris, 14 december 2016 Alberto M. Pereira European Reference Networks: Scope and Context Article
Open Access & research metrics Establishing reliable baselines for science policy
Open Access & research metrics Establishing reliable baselines for science policy Thed van Leeuwen, Rodrigo Costas, Alfredo Yegros-Yegros, and Ingeborg Meijer CWTS, Leiden University STI Conference 2017,
3.1 PHASE 2 OF THE GLOBAL PROJECT
RESULTS CHAPTER 3 3.1 PHASE 2 OF THE GLOBAL PROJECT (1996 1999) This new report of the Global Project provides data on anti-tuberculosis drug resistance from 58 geographical settings. Of these, 28 provided
REPORT ON THE RESEARCH UNIT: Virology Department
Research evaluation REPORT ON THE RESEARCH UNIT: Virology Department UNDER THE SUPERVISION OF THE FOLLOWING INSTITUTIONS AND RESEARCH BODIES: Institut Pasteur Institut National de la Santé et de la Recherche
PPMI 2018 ANNUAL INVESTIGATORS MEETING May 2-3
PPMI 2018 ANNUAL INVESTIGATORS MEETING May 2-3 CAROLINE TANNER M.D., PH.D. PPMI FOUND (FOLLOW-UP OF PERSONS WITH NEUROLOGIC DISEASES) WHAT IS FOUND? FOUND is a method for long term follow-up of research
Direct acting anti-virals: the near future
Direct acting anti-virals: the near future Heiner Wedemeyer Hannover Medical School Germany Will IFN-free treatment be possible in the near future? Interferon-free regimens to treat hepatitis C What should
Planning an effective HPV vaccination launch: The key indicators for success Joakim Dillner
Planning an effective HPV vaccination launch: The key indicators for success Joakim Dillner Professor of Infectious Disease Epidemiology PI, International HPV Reference Center Director, Swedish Cervical
European Network of Quitlines
European Commission Grant Agreement n SI2324433 (2001CVG2-008) Coordinator Contact Information Steve Crone QUIT 211 Old Street London EC1V 9NR Tel: + 44 207251 1551 Fax: +44207251 1661 Email: scrone@quitorguk